C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China · Delayed Price · Currency is CNY 5.07
-0.10 (-1.93%)
Oct 22, 2026, 3:04 PM CST
SHE:000950 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 81,391 | 82,447 | 80,562 | 78,397 | 67,829 | 62,521 |
Revenue Growth | -0.71% | 2.34% | 2.76% | 15.58% | 8.49% | 38.26% |
Gross Profit Gross Profit Growth | 5,542 | 5,833 | 5,921 | 6,235 | 5,791 | 5,703 |
Operating Income Operating Income Growth | 901.83 | 1,132 | 1,232 | 1,957 | 2,177 | 2,177 |
Net Income Net Income Growth | 358.9 | 386.72 | 282.99 | 624.63 | 952.28 | 1,005 |
Earnings Per Share EPS Growth | 0.21 | 0.22 | 0.16 | 0.36 | 0.55 | 0.58 |
EPS Growth | 14.57% | 37.50% | -55.56% | -34.54% | -5.17% | 13.73% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Wholesale Pharmaceutical Wholesale Growth | 76,383 | 77,871 | 76,560 | 75,151 | 65,014 | 60,088 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 4,574 | 4,180 | 3,695 | 3,034 | 2,643 | 2,266 |
Unallocated Other Unallocated Other Growth | 433.06 | 396.6 | 307.01 | 212.62 | 171.83 | 166.87 |
Total Total Growth | 81,391 | 82,447 | 80,562 | 78,397 | 67,829 | 62,521 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,820 | 6,684 | 9,392 | 9,149 | 7,429 | 5,677 |
Total Debt Total Debt Growth | 26,454 | 23,693 | 24,403 | 23,179 | 24,384 | 20,054 |
Net Cash (Debt) Net Cash Growth | -21,633 | -17,009 | -15,012 | -14,030 | -16,955 | -14,377 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -12.55 | -9.68 | -8.49 | -8.09 | -9.79 | -8.29 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -581.27 | 754.67 | -186.74 | 508.53 | 285.83 | 250.16 |
Capital Expenditures CapEx Growth | -351.38 | -299.54 | -250.53 | -244.41 | -268.07 | -489.55 |
Free Cash Flow Free Cash Flow Growth | -932.65 | 455.13 | -437.27 | 264.13 | 17.76 | -239.38 |
Free Cash Flow Growth | - | - | - | 1386.93% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 6.81% | 7.07% | 7.35% | 7.95% | 8.54% | 9.12% |
Operating Margin | 1.11% | 1.37% | 1.53% | 2.50% | 3.21% | 3.48% |
Pretax Margin | 0.77% | 0.81% | 0.69% | 1.23% | 2.17% | 2.53% |
Profit Margin | 0.44% | 0.47% | 0.35% | 0.80% | 1.40% | 1.61% |
FCF Margin | -1.15% | 0.55% | -0.54% | 0.34% | 0.03% | -0.38% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.060 | 0.060 | 0.060 | 0.050 | 0.060 | 0.105 |
Dividend Per Share Growth | 0% | 0% | 20.00% | -16.67% | -42.86% | - |
Dividend Yield | 1.18% | 1.02% | 1.11% | 1.01% | 1.18% | 2.00% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.35 | 26.01 | 32.85 | 13.75 | 9.30 | 8.84 |
Forward PE | - | 11.88 | 13.12 | 7.26 | - | - |
P/FCF Ratio | - | 22.10 | - | 32.52 | 498.57 | - |
PS Ratio | 0.11 | 0.12 | 0.12 | 0.11 | 0.13 | 0.14 |